Genfit SA Ownership
| GNFT Stock | USD 3.79 0.04 1.04% |
Shares in Circulation | First Issued 2004-12-31 | Previous Quarter 60.4 M | Current Value 60.4 M | Avarage Shares Outstanding 26.3 M | Quarterly Volatility 15.2 M |
Genfit Stock Ownership Analysis
The book value of the company was currently reported as 1.39. The company had not issued any dividends in recent years. Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France. Genfit SA operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 134 people. To learn more about Genfit SA call JeanFrancois Mouney at 33 3 20 16 40 00 or check out https://www.genfit.com.Besides selling stocks to institutional investors, Genfit SA also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Genfit SA's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Genfit SA's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Genfit SA Quarterly Liabilities And Stockholders Equity |
|
Genfit Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Genfit SA is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genfit SA backward and forwards among themselves. Genfit SA's institutional investor refers to the entity that pools money to purchase Genfit SA's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Millennium Management Llc | 2025-03-31 | 131.5 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 25.5 K | Old Mission Capital Llc. | 2025-03-31 | 22.2 K | Optiver Holding B.v. | 2025-03-31 | 13.2 K | Citadel Advisors Llc | 2025-03-31 | 12.3 K | Ubs Group Ag | 2025-03-31 | 3.1 K | Rhumbline Advisers | 2025-03-31 | 678 | Bank Of America Corp | 2025-03-31 | 17.0 | Advisor Group Holdings, Inc. | 2025-03-31 | 0.0 |
Genfit SA Outstanding Bonds
Genfit SA issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genfit SA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genfit bonds can be classified according to their maturity, which is the date when Genfit SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Genfit Stock Analysis
When running Genfit SA's price analysis, check to measure Genfit SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genfit SA is operating at the current time. Most of Genfit SA's value examination focuses on studying past and present price action to predict the probability of Genfit SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genfit SA's price. Additionally, you may evaluate how the addition of Genfit SA to your portfolios can decrease your overall portfolio volatility.